Blockchain in Genomics Market to Grow with a CAGR of 11.11% through 2030F

Rising investment by private players & venture capitalists and advancements in genomics is expected to drive the Global Blockchain in Genomics Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Blockchain in Genomics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2020–2030F”, the Global Blockchain in Genomics Market stood at USD 1.06 Billion in 2024 and is anticipated to grow with a CAGR of 11.11% in the forecast period. Rising investments by private players and venture capitalists are significantly accelerating the growth of the Blockchain in Genomic Data Management Market. These financial inflows support innovation, infrastructure development, and strategic partnerships, enabling companies to tackle long-standing challenges in healthcare data management. In parallel, advancements in genomics, growing use of digital tools, and increased patient-driven digitization of healthcare services are fueling broader market expansion.

Blockchain technology offers a decentralized, secure framework for storing, managing, and sharing sensitive genomic and healthcare data, ensuring transparency, immutability, and enhanced privacy. This technology directly addresses major issues such as data interoperability, security breaches, and lack of trust among stakeholders, particularly with the growing adoption of electronic health records (EHRs) and the demand for efficient, secure data exchange systems.

Strategic collaborations involving pharmaceutical companies, governments, and technology providers further validate blockchain's relevance in genomic data management. With high-throughput sequencing technologies generating data at an unprecedented scale, modern infrastructure solutions are critical for handling exabyte-level volumes.

However, concerns around data security, privacy, and user hesitancy in sharing original genome data persist. Blockchain’s use of hashed transactions and metadata sharing helps mitigate these concerns, while also offering opportunities to reduce analysis costs, streamline data ownership, and foster precision medicine through efficient, peer-to-peer transactions.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Blockchain in Genomics Market”

The Global Blockchain in Genomics Market is segmented into business model, service, application, end user, regional distribution, and company.

Based on service, Blockchain Platforms hold a dominant position over Utility Tokens. This is primarily due to their foundational role in enabling secure, decentralized storage and exchange of sensitive genomic data. Blockchain platforms provide the infrastructure necessary for managing large-scale genomic datasets while ensuring data privacy, integrity, and transparency—key concerns in genomics. These platforms facilitate interoperability between stakeholders, such as patients, researchers, healthcare providers, and pharmaceutical companies, allowing for direct data exchange without intermediaries. Features like immutability, smart contracts, and access control mechanisms make blockchain platforms especially suited for applications involving sensitive genomic information. While utility tokens are important for incentivizing user participation and facilitating micro-transactions within blockchain ecosystems, they are secondary to the platforms themselves, which drive the core technological integration in genomic data management. The growing adoption of blockchain platforms by bioinformatics firms, research institutes, and personalized medicine providers reflects their central role. This dominance is further reinforced by strategic partnerships and increased investment from private players seeking robust, scalable solutions for genomic data security and sharing.

Based on region, Asia-Pacific is the fastest-growing region in the global Blockchain in Genomics market due to several converging factors. Rapid advancements in genomic research, increasing government support for digital health initiatives, and rising investments from private players and venture capitalists are driving growth in countries such as China, India, Japan, and South Korea. The region is witnessing a surge in population-scale genomic initiatives aimed at improving healthcare outcomes and advancing precision medicine. Blockchain technology is increasingly being integrated into these efforts to address challenges around data privacy, security, and interoperability. In addition, the rising adoption of electronic health records (EHRs) and growing awareness of personalized medicine are creating a strong demand for secure and efficient genomic data management solutions. Asia-Pacific has a large and genetically diverse population, which offers valuable opportunities for genomic research and data sharing. Governments and research institutions are actively investing in infrastructure to support the collection, analysis, and secure exchange of genomic data. The combination of policy support, technological innovation, and population diversity makes Asia-Pacific a key driver of future growth in the Blockchain in Genomics market.

Major companies operating in Global Blockchain in Genomics Market are:

·         Oxford Nanopore Technologies Plc

·         PacBio (Pacific Biosciences of California Inc.)

·         Guardtime Ltd.

·         Agilent Technologies Inc.

·         Illumina Inc.

·         BioRad Laboratories Inc.

·         10x Genomics Inc.

·         QIAGEN NV

·         Nebula Genomics Inc.

·         Thermo Fisher Scientific

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Blockchain technology is emerging as a key solution for secure genomic data storage and exchange, driven by its success in decentralized information management across sectors like banking and fintech. The rise of cryptocurrencies enables peer-to-peer transactions, reducing reliance on intermediaries. Advances in sequencing technology, lower costs, and increased focus on bio-cybersecurity are propelling market growth. However, limited awareness and high data management costs may restrain progress. Still, strategic partnerships, national initiatives, and investments from private and government stakeholders are creating strong growth opportunities, as blockchain adoption in genomic data management gains momentum within the global healthcare ecosystem”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Blockchain in Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model), By Service (Utility Tokens and Blockchain Platforms), By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Research Institutes, Data Owners, And Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Blockchain in Genomics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Blockchain in Genomics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com